As a result, there are currently several Ozempic lawsuits against Novo Nordisk
The current trial had a higher proportion of males at 35%, especially compared to the STEP non-diabetes trials, which included 19-26% males
The term lipotropic describes any agent that helps the body remove fat or works on the liver to decrease its fat production
Many individuals experience difficulty losing weight due to biological drivers such as increased hunger signals, reduced satiety, insulin resistance, or metabolic adaptation
Conclusion Published clinical trial data paints a consistent picture of the retatrutide adverse event profile and associated risks: GI events are common, dose-dependent, and generally transient , with rates comparable to other GLP-1 class compounds
This is where Noom sets itself apart from every other clinic Ive reviewed